Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studies
Open Access
- 1 February 1983
- Vol. 51 (3) , 402-407
- https://doi.org/10.1002/1097-0142(19830201)51:3<402::aid-cncr2820510308>3.0.co;2-p
Abstract
Intra‐arterial CDP was utilized to treat the primary tumor in 11 pediatric patients with osteosarcoma and in one with malignant fibrous histiocytoma. The investigation commenced with a phase I‐II pilot study in four osteosarcoma patients. A dose of 150 mg/m2 was found to be safe and effective in producing a clinical response. This was followed by a definitive study in the remaining seven osteosarcoma patients and in the one malignant fibrous histiocytoma patient. The results were assessed by specific clinical, pharmacologic, radiographic and pathologic criteria. The overall response in the definitive study was 50% with two patients exhibiting total tumor destruction. The success of intra‐arterial CDP was attributed to its ability to achieve high local drug concentration and tumor penetration. This was demonstrated by pharmacologic studies.This publication has 8 references indexed in Scilit:
- Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcomaCancer, 1981
- Systemic hypertension: A complication of intra-arterial cis-diammine dichloroplatinum (II) infusionCancer, 1981
- Phase I-II trial of percutaneous intra-arterial Cis-diamminedichloro platinum (II) for regionally confined malignancyCancer, 1980
- DNA-PROTEIN AND DNA INTERSTRAND CROSS-LINKING BY CIS-PLATINUM(II) AND TRANS-PLATINUM(II) DIAMMINEDICHLORIDE IN L1210 MOUSE LEUKEMIA-CELLS AND RELATION TO CYTOTOXICITY1979
- Cis‐diamminedichloroplatinum (NSC‐119875) in childhood malignancies: A southwest oncology group studyMedical and Pediatric Oncology, 1978
- Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma.Clinical Chemistry, 1977